International Stem Cell ISCO
OTC ISCO
$0.33 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

International Stem Cell (ISCO) Prepaid Assets (2010 - 2026)

International Stem Cell's (ISCO) quarterly Prepaid Assets came in at $187000.0 in Q2 2026, down 30.48% year-over-year from $269000.0 in Q2 2025, and up 3.31% quarter-over-quarter from $181000.0 in Q4 2025.

Analysis

International Stem Cell (ISCO) Prepaid Assets (2010 - 2026) Analysis & Trends

International Stem Cell (ISCO) has reported Prepaid Assets for 17 consecutive years, with $187000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Prepaid Assets fell 30.48% year-over-year to $187000.0 in Q2 2026; TTM through Jun 2026 was $187000.0, a 30.48% decrease from a year earlier, with the FY2025 full-year figure at $181000.0, up 47.15% from the prior year.
  • Prepaid Assets was $187000.0 for Q2 2026 at International Stem Cell, up from $181000.0 in the prior quarter.
  • Over five years, Prepaid Assets peaked at $384000.0 in Q2 2022 and troughed at $90000.0 in Q4 2022.
  • A 5-year average of $232117.6 and a median of $267000.0 in 2023 frame the typical range for Prepaid Assets.
  • Across the five-year window, Prepaid Assets plunged 55.43% in 2024 and surged 47.15% in 2025, its largest moves.
  • Over 5 years, Prepaid Assets stood at $90000.0 in 2022, then rose by 6.67% to $96000.0 in 2023, then climbed by 28.12% to $123000.0 in 2024, then jumped by 47.15% to $181000.0 in 2025, then climbed by 3.31% to $187000.0 in 2026.
  • The last three Prepaid Assets figures came in at $187000.0 (Q2 2026), $181000.0 (Q4 2025), and $162000.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn -
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn -
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn
10 International Stem Cell 2.84 Mn 1.75 Mn 1.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 187,000.00
Dec 31, 2025 181,000.00
Sep 30, 2025 162,000.00
Jun 30, 2025 269,000.00
Mar 31, 2025 277,000.00
Dec 31, 2024 123,000.00
Sep 30, 2024 119,000.00
Jun 30, 2024 304,000.00
Mar 31, 2024 302,000.00
Dec 31, 2023 96,000.00
Sep 30, 2023 267,000.00
Jun 30, 2023 344,000.00
Mar 31, 2023 311,000.00
Dec 31, 2022 90,000.00
Sep 30, 2022 192,000.00
Jun 30, 2022 384,000.00
Mar 31, 2022 338,000.00
Dec 31, 2021 135,000.00
Sep 30, 2021 174,000.00
Jun 30, 2021 416,000.00